Skip Nav Destination
Committee on Drugs
AAP Policy authored by the Committee on Drugs
From the American Academy of Pediatrics Clinical Report
Rohit P. Shenoi, MD, FAAP; Nathan Timm, MD, FAAP; COMMITTEE ON DRUGS; COMMITTEE ON PEDIATRIC EMERGENCY MEDICINE; Bridgette Jones, MD, FAAP; Kathleen Neville, MD, MS, MBA, FAAP; Jennifer Foster, MD, FAAP; Connie Houck, MD, FAAP; Matthew Laughon, MD, FAAP; Ian Paul, MD, FAAP; Routt J. Reigart, MD, FAAP; Janice Sullivan, MD, FAAP; John van den Anker, MD, PhD, FAAP; Joseph Wright, MD, MPH, FAAP; Terry Adirim, MD, MPH, FAAP; James Callahan, MD, FAAP; Michael Agus, MD, FAAP; Javier Gonzalez del Rey, MD, MEd, FAAP; Toni Gross, MD, MPH, FAAP; Madeline Joseph, MD, FAAP; Natalie Lane, MD, FAAP; Lois Lee, MD, MPH, FAAP; Elizabeth Mack, MD, FAAP; Prashant Mahajan, MD, MPH, MBA, FAAP; Jennifer Marin, MD, FAAP; Suzan Mazor, MD, FAAP
10.1542/peds.2019-3450
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON DRUGS
10.1542/peds.2015-0072
From the American Academy of Pediatrics Clinical Report
Joseph D. Tobias, MD; Thomas P. Green, MD; Charles J. Coté, MD; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE; COMMITTEE ON DRUGS; Rita Agarwal, MD; Corrie T.M. Anderson, MD; Courtney Alan Hardy, MD; Anita Honkanen, MD; Mohamed A. Rehman, MD; Kathleen Neville, MD; Constance S. Houck, MD; Bridgette Jones, MD; Ian M. Paul, MD; Janice E. Sullivan, MD; John N. Van Den Anker, MD
10.1542/peds.2016-2396
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON DRUGS; Kathleen A. Neville, MD; Daniel A.C. Frattarelli, MD; Jeffrey L. Galinkin, MD; Thomas P. Green, MD; Timothy D. Johnson, DO; MMM; Ian M. Paul, MD; John N. Van Den Anker, MD
10.1542/peds.2013-4060
From the American Academy of Pediatrics Clinical Report
Jeffrey Galinkin, MD; Jeffrey Lee Koh, MD; COMMITTEE ON DRUGS; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE; Daniel A. C. Frattarelli, MD; Thomas P. Green, MD; Timothy D. Johnson, DO; Kathleen A. Neville, MD; Ian M. Paul, MD; John N. Van Den Anker, MD; Carolyn Fleming Bannister, MD; Joseph Tobias, MD; Corrie T. M. Anderson, MD; Kenneth R. Goldschneider, MD; David Mark Polaner, MD
10.1542/peds.2013-3398
From the American Academy of Pediatrics Clinical Report
Hari Cheryl Sachs, MD; COMMITTEE ON DRUGS; Daniel A. C. Frattarelli; Jeffrey L. Galinkin; Thomas P. Green; Timothy Johnson; Kathleen Neville; Ian M. Paul; John Van den Anker
10.1542/peds.2013-1985
From the American Academy of Pediatrics Clinical Report
Mark L. Hudak, MD; Rosemarie C. Tan, MD; THE COMMITTEE ON DRUGS; THE COMMITTEE ON FETUS AND NEWBORN; Daniel A. C. Frattarelli, MD; Jeffrey L. Galinkin, MD; Thomas P. Green, MD; Kathleen A. Neville, MD; Ian M. Paul, MD; John N. Van Den Anker, MD; Lu-Ann Papile, MD; Jill E. Baley, MD; Vinod K. Bhutani, MD; Waldemar A. Carlo, MD; James Cummings, MD; Praveen Kumar, MD; Richard A. Polin, MD; Kasper S. Wang, MD; Kristi L. Watterberg, MD
10.1542/peds.2011-3212
From the American Academy of Pediatrics Clinical Report
Janice E. Sullivan, MD; Henry C. Farrar, MD; the SECTION ON CLINICAL PHARMACOLOGY AND THERAPEUTICS; COMMITTEE ON DRUGS
10.1542/peds.2010-3852
From the American Academy of Pediatrics Clinical Report
Robert E. Shaddy, MD; Scott C. Denne, MD; The Committee on Drugs and Committee on Pediatric Research
10.1542/peds.2010-0082
From the American Academy of Pediatrics
Mary A. Hegenbarth, MD; and the Committee on Drugs
10.1542/peds.2007-3284
